Last Updated: 20/03/2026
Translating novel vaccine strategies to early phase clinical trials
Objectives
This project aims to further develop and then test in pre-clinical and clinical trials novel vaccine candidates that to prevent infections with malaria parasites and with Streptococcus pyogenes.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria is responsible for the loss of over 600,000 young lives each year and S. pyogenes is responsible for over 500,000 deaths per year. Australia’s Indigenous populations suffer the highest reported rates of streptococcal-related pathology worldwide.
External reference
Themes
Date
Jan 2015 — Dec 2019
Total Project Funding
$675,235
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1078029
AUD 911,915
Country / Project Site(s)
Related Resources
